| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities | ||||||||||||
Net income | ||||||||||||
129,200 | 694,100 | 751,200 | 780,500 | 846,600 | 271,100 | 318,800 | 270,300 | 185,700 | 182,700 | 0 | 0 | 0 |
Adjustments to reconcile net income to net cash provided by operations: | ||||||||||||
Depreciation and amortization | ||||||||||||
221,000 | 222,200 | 222,600 | 221,200 | 219,600 | 218,500 | 217,300 | 215,600 | 214,800 | 212,200 | 0 | 0 | 0 |
Non-cash currency transaction gain on debt and hedging instruments | ||||||||||||
8,500 | 16,800 | 39,700 | 18,600 | 63,800 | 45,500 | 25,200 | 8,300 | -63,400 | -57,400 | 0 | 0 | 0 |
Premium paid on redemption of long-term debt | ||||||||||||
- | - | - | - | - | 27,000 | 27,000 | 27,000 | 27,000 | 0 | 0 | 0 | 0 |
Other net non-cash financing costs | ||||||||||||
22,500 | 27,400 | 41,900 | 28,300 | 72,300 | 65,600 | 63,300 | 59,200 | 45,400 | 47,600 | 0 | 0 | 0 |
Share-based compensation expense | ||||||||||||
15,300 | 15,000 | 11,000 | 9,200 | 7,000 | 6,000 | 8,000 | 6,900 | 6,200 | 5,400 | 0 | 0 | 0 |
Decrease in post-employment benefit obligations, net | ||||||||||||
-8,800 | -9,400 | -8,500 | -7,200 | -5,800 | -4,600 | -4,300 | -8,300 | -8,400 | -7,400 | 0 | 0 | 0 |
Deferred income taxes | ||||||||||||
-20,300 | -648,400 | -656,500 | -644,800 | -678,200 | -64,900 | -169,800 | -172,500 | -161,800 | -162,800 | 0 | 0 | 0 |
Other operating activities | ||||||||||||
6,300 | 6,000 | 6,700 | 7,100 | 6,400 | 4,800 | 5,300 | 6,300 | 5,600 | 5,500 | 0 | 0 | 0 |
Changes in operating assets and liabilities, net of effects of acquisitions: | ||||||||||||
—Increase in accounts receivable | ||||||||||||
-45,800 | -41,800 | -29,000 | -22,000 | 16,900 | 49,600 | 38,600 | 49,800 | 42,700 | 24,600 | 0 | 0 | 0 |
—Increase in inventories | ||||||||||||
-58,900 | -65,100 | -10,100 | 43,000 | 88,400 | 96,100 | 70,600 | 63,900 | 59,600 | 45,400 | 0 | 0 | 0 |
—Increase (decrease) in accounts payable | ||||||||||||
-2,900 | -48,200 | -64,700 | -53,500 | -7,000 | 42,100 | 36,200 | 64,900 | 49,400 | 49,900 | 0 | 0 | 0 |
—Increase in prepaid expenses and other assets | ||||||||||||
-3,700 | 2,600 | 32,700 | 31,800 | 38,600 | 27,500 | 24,400 | 4,700 | -2,900 | -2,300 | 0 | 0 | 0 |
—(Decrease) increase in taxes payable | ||||||||||||
-43,800 | 46,200 | 39,300 | 29,900 | 38,800 | -15,300 | -6,500 | 9,600 | -1,500 | 6,500 | 0 | 0 | 0 |
—Increase (decrease) in other liabilities | ||||||||||||
9,300 | -43,500 | 6,700 | -15,900 | 300 | -18,100 | -24,200 | -25,500 | -20,500 | -9,400 | 0 | 0 | 0 |
Net cash provided by (used in) operations | ||||||||||||
427,700 | 348,900 | 316,400 | 283,400 | 292,300 | 313,500 | 312,300 | 326,800 | 305,900 | 319,900 | 0 | 0 | 0 |
Cash flows from investing activities | ||||||||||||
Purchases of property, plant and equipment | ||||||||||||
62,900 | 72,100 | 73,600 | 97,600 | 131,500 | 166,100 | 186,300 | 174,300 | 144,400 | 101,100 | 0 | 0 | 0 |
Purchases of intangible assets | ||||||||||||
12,200 | 11,000 | 12,700 | 13,000 | 13,600 | 16,600 | 15,000 | 15,900 | 13,300 | 10,000 | 0 | 0 | 0 |
Cash paid under corporate-owned life insurance policies | ||||||||||||
0 | - | - | 0 | 0 | - | - | 9,600 | 9,200 | 9,500 | 0 | 0 | 0 |
Cash received under corporate-owned life insurance policies | ||||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - | - | - |
Proceeds from the sale of property, plant and equipment | ||||||||||||
- | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 |
Other investing activities | ||||||||||||
-3,900 | -3,800 | 1,400 | 1,200 | 1,700 | 2,600 | -600 | -300 | -400 | -1,200 | 0 | 0 | 0 |
Net cash used in investing activities | ||||||||||||
-70,900 | -78,000 | -99,100 | -117,400 | -205,900 | -243,600 | -334,000 | -322,800 | -274,800 | -227,000 | 0 | 0 | 0 |
Cash flows from financing activities | ||||||||||||
Issuance of shares, net of underwriting costs | ||||||||||||
2,700 | 1,800 | 1,800 | 2,200 | 1,800 | 799,700 | 799,600 | 799,100 | 799,100 | 600 | 0 | 0 | 0 |
Other offering costs | ||||||||||||
- | - | - | - | - | 8,600 | 10,900 | 10,400 | 5,500 | 2,300 | 0 | 0 | 0 |
Buy-back of shares | ||||||||||||
- | - | - | - | - | - | - | - | - | 1,600 | 0 | 0 | 0 |
Proceeds from long-term debt | ||||||||||||
- | - | - | - | - | - | - | - | - | 644,700 | 0 | 0 | 0 |
Payments of long-term debt | ||||||||||||
586,600 | 593,100 | 18,900 | 25,700 | 26,100 | 933,500 | 940,300 | 940,000 | 1,590,000 | 676,900 | 0 | 0 | 0 |
Premium paid on redemption of long-term debt | ||||||||||||
- | - | - | - | - | 27,000 | 27,000 | 27,000 | 27,000 | 0 | 0 | 0 | 0 |
Debt issuance costs paid | ||||||||||||
0 | - | - | - | 0 | - | - | - | - | 18,800 | 0 | 0 | 0 |
Dividends paid to non-controlling interests | ||||||||||||
27,000 | 28,800 | 36,400 | 34,000 | 37,000 | 35,200 | 30,000 | 34,900 | 18,700 | 24,600 | 0 | 0 | 0 |
Other financing activities | ||||||||||||
2,400 | 1,100 | 1,600 | 800 | -300 | 5,700 | 5,800 | 5,300 | 9,800 | 3,600 | 0 | 0 | 0 |
Net cash used in financing activities | ||||||||||||
-49,100 | -59,300 | -51,900 | -57,200 | -67,000 | -198,900 | -204,200 | -209,600 | -353,500 | -75,300 | 0 | 0 | 0 |
Effect of exchange rate changes on cash and cash equivalents and restricted cash | ||||||||||||
-15,300 | 400 | -6,000 | -3,400 | -14,700 | -12,400 | -6,200 | 1,300 | 16,900 | 19,600 | 0 | 0 | 0 |
Net decrease in cash and cash equivalents and restricted cash | ||||||||||||
292,400 | 212,000 | 159,400 | 105,400 | 4,700 | -141,400 | -232,100 | -204,300 | -305,500 | 37,200 | 0 | 0 | 0 |
Supplemental schedule of cash flow information | ||||||||||||
Interest paid | ||||||||||||
124,900 | 150,800 | 128,000 | 136,400 | 135,900 | 157,900 | 171,200 | 203,100 | 203,700 | 198,000 | 0 | 0 | 0 |
Income taxes paid, net | ||||||||||||
94,300 | 108,800 | 120,700 | 122,800 | 121,500 | 114,000 | 103,600 | 96,900 | 90,700 | 84,800 | 0 | 0 | 0 |
Accrued capital expenditures | ||||||||||||
3,300 | 1,800 | 100 | -1,200 | -1,200 | 1,000 | 2,300 | 3,700 | 3,100 | 1,700 | 0 | 0 | 0 |
Accrued deferred offering costs | ||||||||||||
- | - | - | - | - | - | - | 0 | 0 | - | - | 0 | 0 |